Hans-Christian Militzer

This inventor holds 32 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bayer Aktiengesellschaft, Lanxess Deutschland Gmbh, Aicuris Gmbh + Co. Kg.. Active years: 1997-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Christian Militzer. Retrieved from https://idiyas.com/inventor/hans-christian-militzer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 1)

% Patents Active = 46.9

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 75(Granted Patents)

Location History:

Bergisch Gladbach, DE (1997 - 2014)
Odenthal, DE (2002 - 2021)

Company Filing History:

13 out of 12,268

Bayer Aktiengesellschaft

patents

7 out of 389

Lanxess Deutschland Gmbh

patents

4 out of 53

Aicuris Gmbh + Co. Kg.

patents

4. 4 out of 721

Bayer Intellectual Property Gmbh

patents

5. 3 out of 387

Bayer Pharma Aktiengesellschaft

Years Active: 1997-2021

Loading Chart...

Areas of Expertise:

Enantioselective Epoxidation

Pyrazole Derivatives

Triazole Compounds

Dihydroquinazolines

Chiral Phosphorus Compounds

Phenylacetic Acid

Pharmaceuticals

Selective Progesterone Receptor Modulators

Carbonyl Compounds

Insecticidal Compounds

Amino Acids

Micro-organism Combat

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10894805 - Prodrugs of the selective progesterone receptor modulator (SPRM) (11.beta.,17.beta.)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl] -17-(pentafluoroethyl)estra-4,9-dien-3-one (2021-01-19),

2. 10703742 - Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4-triazole derivatives (2020-07-07),

3. 10383876 - Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts (2019-08-20),

4. 10301289 - Method for the preparation of triazole compounds (2019-05-28),

5. 9636344 - Substituted 2,3-dihydroimidazo[1,2-C]quinazoline salts (2017-05-02),

6. 9533972 - Substituted sodium-1H-pyrazole-5-olate (2017-01-03),

7. 8816075 - Process for the preparation of dihydroquinazolines (2014-08-26),

8. 8653074 - Substituted sodium 1H-pyrazol-5-olate (2014-02-18),

9. 8372972 - Process for the preparation of dihydroquinazolines (2013-02-12),

10. 8293899 - Process for reducing 3-heteroaryl-3-oxopropionic acid derivatives (2012-10-23),

11. 8084604 - Process for the preparation of dihydroquinazolines (2011-12-27),

12. 8076285 - Lysobactin amides (2011-12-13),

13. 8034961 - Process for stereoselectively reducing 4-aryl-4-oxobutanoic acid derivatives (2011-10-11),

14. 7847126 - Process for preparing tertiary phosphines (2010-12-07),

15. 7329766 - Process for stereoselectively reducing 4-aryl-4-oxobutanoic acid derivatives (2008-02-12),

Title: The Innovative Journey of Hans-Christian Militzer

Introduction:

Hans-Christian Militzer, a visionary inventor hailing from Odenthal, Germany, has made significant contributions to the field of technology and innovation.

Latest Patents:

Hans-Christian Militzer's latest patents focus on renewable energy solutions, smart home technologies, and advancements in the automotive industry.

Career Highlights:

With a career spanning over two decades, Militzer has been at the forefront of pioneering inventions that have reshaped various industries. His work has been recognized globally for its ingenuity and practical applications.

Collaborations:

Throughout his career, Hans-Christian Militzer has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His collaborative spirit has led to groundbreaking innovations that have had a lasting impact.

Conclusion:

In conclusion, Hans-Christian Militzer's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators worldwide.

Profile summary based on public USPTO records.